Astrazeneca (AZN) Other Operating Expenses (2016 - 2025)
Historic Other Operating Expenses for Astrazeneca (AZN) over the last 16 years, with Q4 2025 value amounting to $100.0 million.
- Astrazeneca's Other Operating Expenses changed 0.0% to $100.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $381.0 million, marking a year-over-year increase of 5119.05%. This contributed to the annual value of $381.0 million for FY2025, which is 5119.05% up from last year.
- Per Astrazeneca's latest filing, its Other Operating Expenses stood at $100.0 million for Q4 2025, which was down 0.0% from $89.0 million recorded in Q3 2025.
- In the past 5 years, Astrazeneca's Other Operating Expenses ranged from a high of $784.0 million in Q2 2023 and a low of $25.0 million during Q3 2024
- In the last 5 years, Astrazeneca's Other Operating Expenses had a median value of $100.0 million in 2024 and averaged $141.3 million.
- Its Other Operating Expenses has fluctuated over the past 5 years, first plummeted by 9437.5% in 2021, then skyrocketed by 54262.3% in 2023.
- Quarter analysis of 5 years shows Astrazeneca's Other Operating Expenses stood at $147.0 million in 2021, then increased by 28.57% to $189.0 million in 2022, then plummeted by 43.39% to $107.0 million in 2023, then decreased by 6.54% to $100.0 million in 2024, then changed by 0.0% to $100.0 million in 2025.
- Its Other Operating Expenses was $100.0 million in Q4 2025, compared to $89.0 million in Q3 2025 and $79.0 million in Q2 2025.